Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
Aim. To evaluate the clinical impact of β-blocker in patients with adequate left ventricular ejection function (LVEF) who underwent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Methods. A total of 10,724 consecutive patients who underwent PCI throughout 2013 were prosp...
Saved in:
Main Authors: | Yan Chen, Xiao-fang Tang, Run-lin Gao, Yue-jin Yang, Bo Xu, Jin-qing Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2020/4351469 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease
by: Entela Bollano, et al.
Published: (2022-06-01) -
Outcomes in heart failure patients discharged to skilled nursing facilities with delirium
by: Jacob Lafo, et al.
Published: (2022-06-01) -
Beta Blocker Therapy in Heart Failure Patients with Active Cocaine Use: A Systematic Review
by: Baldeep K. Mann, et al.
Published: (2020-01-01) -
Usefulness of a personalized algorithm‐based discharge checklist in patients hospitalized for acute heart failure
by: Florent Allain, et al.
Published: (2020-06-01) -
Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock
by: Tara L. Jones, et al.
Published: (2020-06-01)